Health
UK begins trial of multivariant Covid-19 vaccine booster – The Tribune India
London, September 21
A phase one trial of a multivariant Covid-19 vaccine booster drug has got underway among participants aged over 60 in the UK.
The trial, involving GRT-R910, has been launched by US pharmaceutical company Gritstone in collaboration with…
Continue Reading
-
Noosa News22 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business8 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach